Fulgent Genetics Inc.

NASDAQ: FLGT · Real-Time Price · USD
21.91
0.17 (0.78%)
At close: Aug 15, 2025, 9:55 AM

Fulgent Genetics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
55.14M 97.47M 79.51M 164.89M
Short-Term Investments
202.96M 326.68M 773.38M 770.65M
Long-Term Investments
570.35M 444.01M 339.03M 507.01M
Other Long-Term Assets
33.46M 22.75M -287.39M 141.97M
Receivables
69.02M 57.45M 52.75M 143.29M
Inventory
n/a n/a 4.28M 12.21M
Other Current Assets
19.82M 5.83M 22.25M n/a
Total Current Assets
353.57M 507.85M 905.63M 1.07B
Property-Plant & Equipment
105.55M 95.62M 81.35M 62.29M
Goodwill & Intangibles
157.03M 165.11M 293.67M 86.81M
Total Long-Term Assets
866.39M 727.48M 480.42M 204.26M
Total Assets
1.22B 1.24B 1.39B 1.28B
Account Payables
18.36M 15.36M 23.09M 20.49M
Deferred Revenue
29.84M 25.57M 14.09M 34.38M
Short-Term Debt
412K 1.18M 20.64M 21.28M
Other Current Liabilities
24.28M 164K 5.3M 10.68M
Total Current Liabilities
72.9M 73.02M 116.18M 112.84M
Long-Term Debt
2.49M 2.96M 3.37M n/a
Other Long-Term Liabilities
11.54M 10.95M 15.9M 7.53M
Total Long-Term Liabilities
17.91M 29.02M 28.07M 7.53M
Total Liabilities
90.81M 102.04M 116.18M 112.84M
Total Debt
9.23M 15.25M 20.64M 21.28M
Common Stock
3K 3K 3K 3K
Retained Earnings
590.47M 633.17M 801M 657.6M
Comprehensive Income
-368K 1.21M -20.9M -759K
Shareholders Equity
1.13B 1.14B 1.27B 1.17B
Total Investments
773.31M 770.69M 785.76M 1.28B